Medprin Regenerative Medical Technologies: Independent financial advisor report on matters related to the reserved granting of restricted stock incentives for Guangzhou Mapei Regenerative Medical Technology Co., Ltd.'s 2023 plan, as commissioned by Shanghai Xingong YI He Enterprise Management Consulting Co., Ltd.

SZSI · Jun 28

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

迈普医学：上海信公轶禾企业管理咨询有限公司关于广州迈普再生医学科技股份有限公司2023年限制性股票激励计划预留授予相关事项之独立财务顾问报告

Risk Disclaimer

Statement